Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy Planning, Computer-Assisted | 20 | 2018 | 55 | 3.790 |
Why?
|
| Radiometry | 16 | 2017 | 33 | 2.300 |
Why?
|
| Phantoms, Imaging | 10 | 2020 | 36 | 1.860 |
Why?
|
| Brachytherapy | 16 | 2019 | 44 | 1.820 |
Why?
|
| Scattering, Radiation | 8 | 2020 | 36 | 1.650 |
Why?
|
| Radiosurgery | 5 | 2020 | 32 | 1.630 |
Why?
|
| Algorithms | 8 | 2018 | 358 | 1.330 |
Why?
|
| Monte Carlo Method | 7 | 2018 | 49 | 1.100 |
Why?
|
| Lung Neoplasms | 3 | 2020 | 505 | 1.020 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2015 | 34 | 0.930 |
Why?
|
| Radiotherapy Dosage | 18 | 2018 | 93 | 0.920 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 713 | 0.770 |
Why?
|
| Radiotherapy, Image-Guided | 2 | 2018 | 7 | 0.720 |
Why?
|
| Molecular Imaging | 1 | 2020 | 4 | 0.720 |
Why?
|
| Computer Simulation | 7 | 2018 | 193 | 0.650 |
Why?
|
| Electrons | 3 | 2009 | 17 | 0.620 |
Why?
|
| Photons | 1 | 2018 | 4 | 0.600 |
Why?
|
| Models, Biological | 3 | 2004 | 304 | 0.580 |
Why?
|
| Breast Neoplasms | 8 | 2017 | 353 | 0.570 |
Why?
|
| Skin | 2 | 2012 | 103 | 0.480 |
Why?
|
| Magnetics | 2 | 2005 | 3 | 0.470 |
Why?
|
| Radiation Injuries | 2 | 2012 | 25 | 0.420 |
Why?
|
| Thermal Conductivity | 1 | 2012 | 2 | 0.410 |
Why?
|
| Thermography | 1 | 2012 | 13 | 0.410 |
Why?
|
| Particle Accelerators | 3 | 2009 | 5 | 0.410 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 160 | 0.400 |
Why?
|
| Whole-Body Irradiation | 1 | 2012 | 10 | 0.400 |
Why?
|
| Humans | 32 | 2020 | 26049 | 0.370 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2011 | 3 | 0.370 |
Why?
|
| Tomography, Spiral Computed | 1 | 2011 | 27 | 0.370 |
Why?
|
| Radiotherapy, Intensity-Modulated | 3 | 2020 | 27 | 0.360 |
Why?
|
| Sensitivity and Specificity | 10 | 2015 | 485 | 0.350 |
Why?
|
| Radiotherapy | 3 | 2009 | 31 | 0.350 |
Why?
|
| Computer-Aided Design | 1 | 2009 | 15 | 0.340 |
Why?
|
| Radiotherapy, Conformal | 3 | 2005 | 14 | 0.330 |
Why?
|
| Software | 2 | 2011 | 64 | 0.330 |
Why?
|
| Holography | 1 | 2009 | 1 | 0.330 |
Why?
|
| Quality Assurance, Health Care | 3 | 2016 | 38 | 0.310 |
Why?
|
| Catheterization | 2 | 2005 | 41 | 0.310 |
Why?
|
| Reproducibility of Results | 9 | 2012 | 670 | 0.270 |
Why?
|
| Imaging, Three-Dimensional | 4 | 2011 | 216 | 0.270 |
Why?
|
| Software Validation | 1 | 2005 | 1 | 0.250 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 32 | 0.250 |
Why?
|
| Prostatic Neoplasms | 2 | 2018 | 89 | 0.250 |
Why?
|
| Equipment Design | 8 | 2012 | 141 | 0.240 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2005 | 53 | 0.240 |
Why?
|
| Neurosurgical Procedures | 1 | 2005 | 124 | 0.220 |
Why?
|
| Posture | 1 | 2003 | 63 | 0.220 |
Why?
|
| Stents | 5 | 2004 | 73 | 0.220 |
Why?
|
| Ethmoid Sinus | 1 | 2003 | 10 | 0.220 |
Why?
|
| Lung | 1 | 2003 | 155 | 0.200 |
Why?
|
| Intraoperative Care | 2 | 2017 | 37 | 0.200 |
Why?
|
| Female | 17 | 2015 | 14411 | 0.180 |
Why?
|
| Electrical Equipment and Supplies | 1 | 2019 | 2 | 0.170 |
Why?
|
| Research Report | 1 | 2019 | 7 | 0.170 |
Why?
|
| Equipment Failure Analysis | 5 | 2012 | 100 | 0.160 |
Why?
|
| Coronary Restenosis | 3 | 2004 | 10 | 0.160 |
Why?
|
| Graft Occlusion, Vascular | 3 | 2004 | 18 | 0.160 |
Why?
|
| Body Burden | 2 | 2012 | 6 | 0.160 |
Why?
|
| Societies, Medical | 1 | 2019 | 146 | 0.160 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2018 | 5 | 0.150 |
Why?
|
| Proton Therapy | 1 | 2018 | 2 | 0.150 |
Why?
|
| Acoustics | 1 | 2018 | 19 | 0.150 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 29 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 91 | 0.140 |
Why?
|
| Strontium Radioisotopes | 4 | 2003 | 9 | 0.130 |
Why?
|
| Radiation Dosage | 1 | 2015 | 35 | 0.120 |
Why?
|
| Intestine, Small | 1 | 2015 | 28 | 0.120 |
Why?
|
| Angioplasty, Balloon, Coronary | 3 | 2004 | 38 | 0.120 |
Why?
|
| Gamma Rays | 1 | 2015 | 16 | 0.120 |
Why?
|
| Treatment Outcome | 8 | 2013 | 3293 | 0.120 |
Why?
|
| Beta Particles | 3 | 2003 | 8 | 0.110 |
Why?
|
| Organs at Risk | 1 | 2013 | 8 | 0.110 |
Why?
|
| Urinary Bladder | 1 | 2013 | 19 | 0.110 |
Why?
|
| Rectum | 1 | 2013 | 43 | 0.110 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 48 | 0.110 |
Why?
|
| Risk Assessment | 4 | 2019 | 622 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 141 | 0.110 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2017 | 42 | 0.110 |
Why?
|
| Artifacts | 2 | 2011 | 33 | 0.110 |
Why?
|
| Mice | 2 | 2012 | 1281 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 1066 | 0.090 |
Why?
|
| X-Ray Film | 1 | 2011 | 3 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2012 | 378 | 0.090 |
Why?
|
| Calibration | 1 | 2009 | 16 | 0.080 |
Why?
|
| Metals | 1 | 2011 | 142 | 0.080 |
Why?
|
| Radiographic Image Enhancement | 1 | 2009 | 27 | 0.080 |
Why?
|
| Biomarkers | 1 | 2012 | 551 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 69 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2009 | 73 | 0.080 |
Why?
|
| Quality Control | 3 | 2019 | 27 | 0.080 |
Why?
|
| Animals | 2 | 2012 | 3391 | 0.070 |
Why?
|
| Middle Aged | 9 | 2005 | 8511 | 0.070 |
Why?
|
| Radiotherapy, High-Energy | 2 | 2003 | 4 | 0.070 |
Why?
|
| Esthetics | 1 | 2005 | 11 | 0.060 |
Why?
|
| Iridium Radioisotopes | 1 | 2005 | 2 | 0.060 |
Why?
|
| Coronary Angiography | 2 | 2003 | 68 | 0.060 |
Why?
|
| Bacterial Infections | 1 | 2005 | 49 | 0.060 |
Why?
|
| Radiation Protection | 1 | 2004 | 5 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 2004 | 24 | 0.060 |
Why?
|
| Relative Biological Effectiveness | 1 | 2004 | 4 | 0.060 |
Why?
|
| Contrast Media | 1 | 2004 | 60 | 0.060 |
Why?
|
| Coronary Stenosis | 1 | 2004 | 15 | 0.060 |
Why?
|
| Supine Position | 1 | 2003 | 17 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2004 | 122 | 0.050 |
Why?
|
| Prone Position | 1 | 2003 | 32 | 0.050 |
Why?
|
| Aged | 7 | 2005 | 8719 | 0.050 |
Why?
|
| Anisotropy | 1 | 2003 | 51 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 184 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 277 | 0.050 |
Why?
|
| Follow-Up Studies | 5 | 2006 | 1713 | 0.050 |
Why?
|
| Visual Perception | 1 | 2002 | 35 | 0.050 |
Why?
|
| Mastectomy, Segmental | 3 | 2005 | 13 | 0.050 |
Why?
|
| Male | 7 | 2018 | 14025 | 0.040 |
Why?
|
| Neoplasms | 1 | 2003 | 219 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 10 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2005 | 1663 | 0.040 |
Why?
|
| Water | 1 | 2017 | 29 | 0.040 |
Why?
|
| Adult | 3 | 2005 | 7367 | 0.040 |
Why?
|
| Automation | 1 | 2016 | 8 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2006 | 8 | 0.030 |
Why?
|
| Internet | 1 | 2016 | 81 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2004 | 930 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2003 | 17 | 0.030 |
Why?
|
| Body Water | 1 | 2012 | 2 | 0.030 |
Why?
|
| Mice, Hairless | 1 | 2012 | 2 | 0.030 |
Why?
|
| Tomography | 1 | 2012 | 12 | 0.030 |
Why?
|
| Radiography | 2 | 2004 | 610 | 0.030 |
Why?
|
| Survival Rate | 2 | 2004 | 321 | 0.020 |
Why?
|
| Incidence | 2 | 2005 | 714 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 362 | 0.020 |
Why?
|
| Myocardial Infarction | 2 | 2003 | 134 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 457 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2003 | 305 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2009 | 42 | 0.020 |
Why?
|
| Age Distribution | 1 | 2005 | 81 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2005 | 4674 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2005 | 235 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2005 | 35 | 0.020 |
Why?
|
| Angiography | 1 | 2004 | 27 | 0.010 |
Why?
|
| Radiology, Interventional | 1 | 2004 | 6 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2003 | 3305 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 105 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2003 | 20 | 0.010 |
Why?
|
| Film Dosimetry | 1 | 2003 | 1 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 110 | 0.010 |
Why?
|
| Myocardial Revascularization | 1 | 2003 | 15 | 0.010 |
Why?
|
| Miniaturization | 1 | 2002 | 2 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 148 | 0.010 |
Why?
|
| Death | 1 | 2003 | 47 | 0.010 |
Why?
|
| Illinois | 1 | 2003 | 227 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 295 | 0.010 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2002 | 7 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2002 | 202 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 13 | 0.010 |
Why?
|
| Random Allocation | 1 | 2002 | 119 | 0.010 |
Why?
|
| Recurrence | 1 | 2002 | 306 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2003 | 127 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 216 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2005 | 1829 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 2246 | 0.010 |
Why?
|
| Reoperation | 1 | 2002 | 874 | 0.010 |
Why?
|